Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 4/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.30 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30952994 | 0.95 | IL17A (0.40) | IL17AABCB11CHRM2SLCO1B1CCNE1 | |
| SCHEMBL30953091 | 0.95 | IL17A (0.40) | IL17AABCB11CHRM2SLCO1B1CCNE1 | |
| SCHEMBL30952951 | 0.95 | IL17A (0.40) | IL17AABCB11CHRM2SLCO1B1CCNE1 | |
| SCHEMBL30952978 | 0.93 | IL17A (0.34) | IL17AABCB11CHRM2SLCO1B1NR3C2 | |
| SCHEMBL30953399 | 0.92 | IL17A (0.42) | IL17AABCB11CHRM2SLCO1B1NR3C2 | |
| SCHEMBL30952982 | 0.92 | IL17A (0.40) | IL17AABCB11CHRM2SLCO1B1CCNE1 | |
| SCHEMBL30952960 | 0.91 | IL17A (0.39) | IL17AABCB11CHRM2SLCO1B1CCNE1 | |
| SCHEMBL30953094 | 0.90 | IL17A (0.35) | IL17ANR3C2 | |
| SCHEMBL30953000 | 0.90 | IL17A (0.44) | IL17AABCB11CHRM2SLCO1B1CCNE1 | |
| SCHEMBL30952970 | 0.87 | IL17A (0.38) | IL17AABCB11CHRM2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | claimed |
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |